Pneumovax 23 PFS 10S
Ended Awarded Last action
- Contract number
- SPE2DR26FAUAX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,467
Award facts
- Contract value 100% obligated
- $11,467.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,467.14 to AmerisourceBergen Drug Corp for the supply of Pneumovax 23 (pneumococcal polysaccharide vaccine 23-valent) in prefilled syringes on January 20, 2026. This firm fixed-price contract, with an ultimate completion date of February 17, 2026, represents a competitively awarded, non-set-aside procurement with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is executed under the company's parent organization, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 31, 2031, serving as the overarching vehicle for pharmaceutical and medical supply delivery to military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor positioned as a critical vendor within the federal medical procurement ecosystem, particularly for military and veteran healthcare systems. The company's extensive contract portfolio with DLA demonstrates its capability to supply a comprehensive range of pharmaceutical products, vaccines, and medical supplies across multiple therapeutic domains. This award for Pneumovax 23 reflects the ongoing operational need for preventive vaccines within the defense health enterprise, supporting immunization requirements across military treatment facilities and allied healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FAUAX?
SPE2DR26FAUAX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FAUAX worth?
The government has obligated $11,467 on SPE2DR26FAUAX.
Is contract SPE2DR26FAUAX an order under another contract?
Yes. SPE2DR26FAUAX is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FAUAX competed?
The extent of competition for SPE2DR26FAUAX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award